RxDoctor Payments Data

Eric Ward

Primary Podiatric Medicine · Matthews, NCNPI 1154332815

Payments from drug & device makers

What this record shows

Treace Medical Concepts, Inc. accounts for 64.4% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2021 at $2,456 and has fallen 78.7% since, to $523 in 2025. Among primary podiatric medicine clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,292in general payments, 2019–2025

Across 87 payments — averaging $83.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$5K
  • Amgen$607
  • Stryker$441
  • Smith+Nephew$293
  • Paratek Pharmaceuticals, Inc.$192
  • Linvatec Corporation$171
  • plus $887 from 21 others

What the payments were for

  • Travel & lodging$3,73651%
  • Food & beverage$3,55749%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,292 in reported general payments places this provider in the 90th percentile of 64 primary podiatric medicine providers in North Carolina.

See all primary podiatric medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$108,878
Medicare patients
504
Services billed
2,006

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Terbinafine Hcl25$156

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Matthews

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →